Base Editing Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Base Editing Market

Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: BT 8891 Dec, 2023, by marketsandmarkets.com

The base editing market in terms of revenue was estimated to be worth $270 million in 2023 and is poised to reach $549 million by 2028, growing at a CAGR of 15.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.

Base Editing Market - Global Forecast to 2028

Base Editing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Base Editing Market

Base Editing Market

Global Base Editing Market Dynamics

Driver: Rising prevalence of rare diseases

As the prevalence of rare and orphan diseases continues to rise, there is a growing demand for innovative therapies to address them. This surge in demand has put gene editing technologies at the forefront of rare disease research and treatment. Since rare diseases often stem from genetic mutations, approaches like base editing are now playing a pivotal role in the quest for effective treatments. This increase in the prevalence of rare diseases is expected to drive substantial growth in the base editing market in the coming years, as researchers and medical professionals work to develop novel therapies for these challenging conditions.

Restraint: Ethical & safety concerns

The application of gene editing, even when carried out with noble intentions, carries inherent risks of unforeseen consequences. Alterations made to a single gene can inadvertently influence the regulation of other genes, potentially resulting in unanticipated and long-term effects. The introduction of base editing technology has given rise to legitimate ethical and safety concerns, which serve as significant barriers to its widespread adoption in the market. While base editing is generally recognized for its increased precision compared to traditional CRISPR-Cas9 methods, it is not entirely immune to the possibility of off-target effects. The inadvertent modifications to DNA can give rise to detrimental outcomes, necessitating a vigilant focus on enhancing the safety and specificity of base editing techniques to minimize these risks. As technology continues to advance, it is imperative to engage in transparent and inclusive dialogues aimed at addressing these concerns. This entails weighing the potential benefits against the associated risks and steadfastly upholding ethical and safety principles to navigate the complex landscape of gene editing.

Opportunity: Increasing pipeline of gene therapy & regulatory approvals

The expanding pipeline for gene therapy in the base editing market presents significant opportunities for advancements in the treatment of genetic disorders and other diseases. Gene therapy involves the delivery of therapeutic genes or gene editing tools into the patient's cells to correct genetic mutations, restore normal gene function, or introduce therapeutic genes for targeted treatment. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and the treatment of previously incurable diseases. The base editing market is expected to benefit from the growing number of gene therapy products in the pipeline. There are over 1,000 gene therapy products in development, with over 200 of these products in clinical trials. Most of these products are targeting cancer, but there are also several products targeting genetic disorders, such as haemophilia and cystic fibrosis. For instance, in 2022, the FDA approved the first gene therapy product for the treatment of cancer.

Challenge: Challenges associated with off-target effects

The primary concern with off-target effects is the unintentional modification of DNA sequences at locations other than the intended target. Even minimal off-target changes can lead to undesirable and potentially harmful consequences, such as introducing new mutations or disrupting the function of other genes. While base editors are designed to recognize a specific DNA sequence, they may still bind to similar sequences in the genome, resulting in off-target effects. Developing base editors with enhanced specificity is an ongoing challenge. Researchers are continually working to improve the design and engineering of base editors to reduce the risk of off-target effects. This includes refining the binding domains and the catalytic mechanisms to increase precision.

Global Base Editing Market Ecosystem Analysis

The ecosystem of base editing consists of end users from pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations base editing product and service providers, reagent & kits suppliers, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of base editing products and services, enhance drug discovery processes, and develop new therapeutics.

Base Editing Market Ecosystem

Platform held a dominant share in the product & service segment in the base editing industry.

By product and service, the base editing market has been further categorized as product and services. Service segment is further categorized as gRNA design, cell line engineering, and other services. The product segment is further categorized as platform, kits & reagents, plasmids, and base editing libraries. In 2022, platform accounted for the largest share of the base editing market. Base editing platforms are integral for therapeutic genome editing applications, where precision and efficiency are critical. Pharmaceutical and biotechnology companies developing gene therapies prefer comprehensive base editing platforms to ensure accurate and reliable results in therapeutic interventions.

The Cytosine base editor segment is expected to register the fastest growth in the base editing industry during the forecast period.

Based on the targeted base the base editing market has been segmented into cytosine base editor and adenine base editor. In 2022, cytosine base editor accounted for the largest share. This can be attributed to the fact that cytosine base editing allows researchers to model disease-causing mutations more easily by introducing specific changes associated with certain genetic disorders. Technological advancements in the field of proteomics and genomics are expected to support the growth of this segment.

North America accounted for the largest share in Base editing industry in 2022.

Base Editing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Geographically, the Base editing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held the dominant share followed by Europe. North America has a well-established infrastructure for funding research and development initiatives, providing financial support to companies working on base editing technologies. Moreover, the regulatory environment in North America is often supportive of innovation in the life sciences sector.

Key players in the global Base editing market include Danaher Corporation (US), Merck KGaA (Germany), Revvity (US), Maravai LifeSciences (US), GenScript (China), Beam Therapeutics (US), Intellia Therapeutics, Inc. (US), Cellectis (France), ElevateBio (US), Creative Biogene (US), Bio Palette Co., Ltd (Japan), Addgene (US), Synthego (US), EdiGene, Inc. (China), Shape TX (US), Pairwise (US), ProQR Therapeutics (Netherlands), QI-Biodesign (China), KromaTiD, Inc. (US), and GenKOre. (South Korea).

Scope of the Base Editing Industry

Report Metric

Details

Market Revenue in 2023

$270 million

Projected Revenue by 2028

$549 million

Revenue Rate

Poised to Grow at a CAGR of 15.2%

Market Driver

Rising prevalence of rare diseases

Market Opportunity

Increasing pipeline of gene therapy & regulatory approvals

This report categorizes the base editing market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

  • Product
    • Platform
    • Kits & Reagents
    • Plasmids
    • Base Editing Libraries
  • Services
    • gRNA Design
    • Cell line engineering
    • Other Services

By Type

  • DNA base editing
  • RNA base editing

By Targeted base

  • Cytosine base editing
  • Adenine base editing

By Application

  • Drug Discovery & Development
  • Agriculture
  • Veterinary

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East & Africa
    • Middle East
    • Africa

Recent Developments of Base Editing Industry

  • In May 2023, Revvity entered into a license agreement with AstraZeneca for the technology underlying its Pin-point base editing system, a next-generation modular gene editing platform with a strong safety profile to support their creation of cell therapies for the treatment of cancer and immune-mediated diseases.
  • In July 2022, Beam Therapeutics entered a collaboration with Verve Therapeutics. Beam Tx granted Verve Tx a license toward an additional liver-mediated cardiovascular disease target.
  • In February 2022, Intellia Therapeutics acquired Rewrite Therapeutics; a private biotechnology company focused on advancing novel DNA writing technologies. This acquisition has expanded Intellia’s industry-leading genome editing toolbox by adding a platform that is highly complementary to its existing CRISPR/Cas9 and base editing technologies.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION AND SCOPE 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY 
    1.4 STAKEHOLDERS 
    1.5 LIMITATIONS 
    1.6 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 43)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES: BASE EDITING MARKET
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 3 BASE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 6 BASE EDITING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
          FIGURE 7 BASE EDITING MARKET (DEMAND-SIDE): CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           2.3.1 DATA TRIANGULATION
                    FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS 
    2.5 RISK ANALYSIS 
    2.6 IMPACT OF RECESSION ON BASE EDITING MARKET 
          TABLE 1 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 2 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 53)
    FIGURE 9 BASE EDITING PRODUCTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 10 BASE EDITING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 BASE EDITING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 BASE EDITING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BASE EDITING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 BASE EDITING MARKET OVERVIEW 
          FIGURE 14 GROWING FOCUS ON GENOMIC STUDIES TO DRIVE MARKET
    4.2 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION AND COUNTRY (2022) 
          FIGURE 15 DRUG DISCOVERY & DEVELOPMENT SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.3 BASE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 16 SOUTH KOREA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 BASE EDITING MARKET SHARE, BY END USER, 2023 
          FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET IN 2023
 
5 MARKET OVERVIEW (Page No. - 60)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 18 BASE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 3 IMPACT ANALYSIS: BASE EDITING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Increasing government funding and growing focus on genomic studies
                    5.2.1.2 Increased applications of genomic research in pharmaceuticals
                    5.2.1.3 Rising prevalence of rare diseases
                    5.2.1.4 Increased precision, better safety, and reduced off-target effects
           5.2.2 RESTRAINTS
                    5.2.2.1 Ethical and safety concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing pipeline of gene therapy products and regulatory approvals
                                FIGURE 19 ONGOING CLINICAL TRIALS FOR GENE THERAPY BY PHASE (TILL Q2 2023)
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of expertise to develop base editors with higher specificity
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
           FIGURE 20 REVENUE SHIFT AND NEW POCKETS FOR BASE EDITING PRODUCT PROVIDERS
    5.4 PRICING ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE OF KEY PRODUCTS IN MARKET
          TABLE 5 COST OF PRODUCT, BY REGION
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 21 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES ADD MAXIMUM VALUE
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 22 BASE EDITING MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM MARKET MAP 
          FIGURE 23 BASE EDITING MARKET: ECOSYSTEM MARKET MAP
          TABLE 6 BASE EDITING MARKET: ROLE IN ECOSYSTEM
    5.8 TECHNOLOGY ANALYSIS 
          TABLE 7 BASE EDITING MARKET: TECHNOLOGY ANALYSIS
    5.9 PATENT ANALYSIS 
          FIGURE 24 PATENT APPLICATIONS FOR BASE EDITING MARKET,  JANUARY 2013–OCTOBER 2023
          TABLE 8 INDICATIVE LIST OF PATENTS IN BASE EDITING MARKET
    5.10 KEY CONFERENCES & EVENTS 
           TABLE 9 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024
    5.11 REGULATORY SCENARIO 
           5.11.1 REGULATORY ANALYSIS
           5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 15 BASE EDITING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF SUPPLIERS
           5.12.4 BARGAINING POWER OF BUYERS
           5.12.5 INTENSITY OF COMPETITIVE RIVALRY
    5.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                    5.13.1.1 Role of stakeholders in buying process
           5.13.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR END USERS
 
6 BASE EDITING MARKET, BY PRODUCT & SERVICE (Page No. - 85)
    6.1 INTRODUCTION 
          TABLE 16 BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
    6.2 PRODUCTS 
          TABLE 1 BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 2 BASE EDITING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 3 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 4 EUROPE: BASE EDITING PRODUCTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 5 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 6 LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 7 MIDDLE EAST & AFRICA: BASE EDITING PRODUCTS MARKET, BY REGION,  2021–2028 (USD MILLION)
           6.2.1 PLATFORMS
                    6.2.1.1 Repetitive purchase of technology platforms to support market growth
                                TABLE 8 PLATFORMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 9 NORTH AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 10 EUROPE: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 11 ASIA PACIFIC: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 12 LATIN AMERICA: PLATFORMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 13 MIDDLE EAST & AFRICA: PLATFORMS MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.2 KITS & REAGENTS
                    6.2.2.1 Increasing prevalence of rare diseases to drive growth
                                TABLE 14 KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 15 NORTH AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 16 EUROPE: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 17 ASIA PACIFIC: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 18 LATIN AMERICA: KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 19 MIDDLE EAST & AFRICA: KITS & REAGENTS MARKET, BY REGION,  2021–2028 (USD MILLION)
           6.2.3 PLASMIDS
                    6.2.3.1 Plasmid-encoded base editors crucial tool for in vivo base editing
                                TABLE 20 PLASMIDS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 21 NORTH AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 22 EUROPE: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 23 ASIA PACIFIC: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 24 LATIN AMERICA: PLASMIDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 25 MIDDLE EAST & AFRICA: PLASMIDS MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.2.4 BASE EDITING LIBRARIES
                    6.2.4.1 Increased application of base editing in therapeutics to drive growth
                                TABLE 26 BASE EDITING LIBRARIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 27 NORTH AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 28 EUROPE: BASE EDITING LIBRARIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 29 ASIA PACIFIC: BASE EDITING LIBRARIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 30 LATIN AMERICA: BASE EDITING LIBRARIES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 31 MIDDLE EAST & AFRICA: BASE EDITING LIBRARIES MARKET, BY REGION,  2021–2028 (USD MILLION)
    6.3 SERVICES 
          TABLE 32 BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 33 BASE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 34 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 35 EUROPE: BASE EDITING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 36 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 37 LATIN AMERICA: BASE EDITING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
          TABLE 38 MIDDLE EAST & AFRICA: BASE EDITING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
           6.3.1 GRNA DESIGNING
                    6.3.1.1 Wide application of gene editing/genome engineering services to drive growth
                                TABLE 39 GRNA DESIGNING MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 40 NORTH AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 41 EUROPE: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 42 ASIA PACIFIC: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 LATIN AMERICA: GRNA DESIGNING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 MIDDLE EAST & AFRICA: GRNA DESIGNING MARKET, BY REGION,  2021–2028 (USD MILLION)
           6.3.2 CELL LINE ENGINEERING
                    6.3.2.1 Cell line engineering tools valuable in drug discovery and therapeutic screening
                                TABLE 45 CELL LINE ENGINEERING MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 46 NORTH AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 47 EUROPE: CELL LINE ENGINEERING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 48 ASIA PACIFIC: CELL LINE ENGINEERING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 49 LATIN AMERICA: CELL LINE ENGINEERING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                                TABLE 50 MIDDLE EAST & AFRICA: CELL LINE ENGINEERING MARKET, BY REGION,  2021–2028 (USD MILLION)
           6.3.3 OTHER SERVICES
                    TABLE 51 OTHER SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 52 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 55 LATIN AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 56 MIDDLE EAST & AFRICA: OTHER SERVICES MARKET, BY REGION,  2021–2028 (USD MILLION)
 
7 BASE EDITING MARKET, BY TYPE (Page No. - 109)
    7.1 INTRODUCTION 
          TABLE 57 BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
    7.2 DNA BASE EDITING 
           7.2.1 CONTINUOUS RESEARCH AND IMPROVEMENTS IN BASE EDITING TECHNOLOGY TO DRIVE MARKET
                    TABLE 58 DNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 59 NORTH AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 60 EUROPE: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 61 ASIA PACIFIC: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 LATIN AMERICA: DNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 MIDDLE EAST & AFRICA: DNA BASE EDITING MARKET, BY REGION,  2021–2028 (USD MILLION)
    7.3 RNA BASE EDITING 
           7.3.1 REVERSIBLE TRANSITION WITH RNA BASE EDITING TO SUPPORT MARKET GROWTH
                    TABLE 64 RNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 65 NORTH AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 66 EUROPE: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 67 ASIA PACIFIC: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 68 LATIN AMERICA: RNA BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 69 MIDDLE EAST & AFRICA: RNA BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
 
8 BASE EDITING MARKET, BY TARGETED BASE (Page No. - 116)
    8.1 INTRODUCTION 
          TABLE 70 BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
    8.2 CYTOSINE BASE EDITING 
           8.2.1 INCREASED USE IN BIOTECHNOLOGY AND AGRICULTURE TO DRIVE MARKET
                    TABLE 71 CYTOSINE BASE EDITING MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 72 NORTH AMERICA: CYTOSINE BASE EDITING MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 73 EUROPE: CYTOSINE BASE EDITING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 74 ASIA PACIFIC: CYTOSINE BASE EDITING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 75 LATIN AMERICA: CYTOSINE BASE EDITING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 76 MIDDLE EAST & AFRICA: CYTOSINE BASE EDITING MARKET,  BY REGION, 2021–2028 (USD MILLION)
    8.3 ADENINE BASE EDITING 
           8.3.1 ONGOING RESEARCH FOR INCREASING EFFICIENCY AND APPLICATIONS TO DRIVE MARKET
                    TABLE 77 ADENINE BASE EDITING MARKET, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 78 NORTH AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 79 EUROPE: ADENINE BASE EDITING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 80 ASIA PACIFIC: ADENINE BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 81 LATIN AMERICA: ADENINE BASE EDITING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 82 MIDDLE EAST & AFRICA: ADENINE BASE EDITING MARKET,  BY REGION, 2021–2028 (USD MILLION)
 
9 BASE EDITING MARKET, BY APPLICATION (Page No. - 123)
    9.1 INTRODUCTION 
          TABLE 83 BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 DRUG DISCOVERY & DEVELOPMENT 
           9.2.1 GROWING RESEARCH IN DRUG DISCOVERY TO DRIVE MARKET
                    TABLE 84 BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION,  2021–2028 (USD MILLION)
                    TABLE 85 NORTH AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 EUROPE: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 ASIA PACIFIC: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 88 LATIN AMERICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT,  BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 89 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
    9.3 AGRICULTURE 
           9.3.1 INCREASING FUNDING FROM GOVERNMENT BODIES AND PRIVATE ORGANIZATIONS TO DRIVE MARKET
                    TABLE 90 BASE EDITING MARKET FOR AGRICULTURE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 91 NORTH AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 92 EUROPE: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 94 LATIN AMERICA: BASE EDITING MARKET FOR AGRICULTURE, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 95 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR AGRICULTURE, BY REGION,  2021–2028 (USD MILLION)
    9.4 VETERINARY 
           9.4.1 INCREASING USE OF ANIMAL SIMULATION MODELS IN RESEARCH TO DRIVE MARKET
                    TABLE 96 BASE EDITING MARKET FOR VETERINARY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 97 NORTH AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 98 EUROPE: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 99 ASIA PACIFIC: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 LATIN AMERICA: BASE EDITING MARKET FOR VETERINARY, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 101 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR VETERINARY, BY REGION,  2021–2028 (USD MILLION)
 
10 BASE EDITING MARKET, BY END USER (Page No. - 133)
     10.1 INTRODUCTION 
             TABLE 102 BASE EDITING MARKET, BY END USER,  2021–2028 (USD MILLION)
     10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             10.2.1 INCREASED USE OF CRISPR-BASED TECHNOLOGIES TO DRIVE MARKET
                        TABLE 103 BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY REGION, 2021–2028 (USD MILLION)
                        TABLE 104 NORTH AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 105 EUROPE: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 106 ASIA PACIFIC: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 107 LATIN AMERICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 108 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
     10.3 ACADEMIC & RESEARCH INSTITUTES 
             10.3.1 GROWING FOCUS ON LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
                        TABLE 109 BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY REGION, 2021–2028 (USD MILLION)
                        TABLE 110 NORTH AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 111 EUROPE: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 112 ASIA PACIFIC: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 113 LATIN AMERICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 114 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
     10.4 CONTRACT RESEARCH ORGANIZATIONS 
             10.4.1 GROWING ADOPTION OF STEM CELL THERAPY AND ONGOING CLINICAL RESEARCH TO PROPEL MARKET
                        TABLE 115 BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION,  2021–2028 (USD MILLION)
                        TABLE 116 NORTH AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 117 EUROPE: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 118 ASIA PACIFIC: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 119 LATIN AMERICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,  BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 120 MIDDLE EAST & AFRICA: BASE EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)
 
11 BASE EDITING MARKET, BY REGION (Page No. - 142)
     11.1 INTRODUCTION 
             TABLE 121 BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 27 NORTH AMERICA: BASE EDITING MARKET SNAPSHOT
             TABLE 122 NORTH AMERICA: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 123 NORTH AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 124 NORTH AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 125 NORTH AMERICA: BASE EDITING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 126 NORTH AMERICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 127 NORTH AMERICA: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
             TABLE 128 NORTH AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 129 NORTH AMERICA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Robust investment in genomics field to drive market
                                      TABLE 130 US: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 131 US: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 132 US: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 133 US: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 134 US: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 135 US: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 136 US: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Availability of government funding for genomics research to support market growth
                                      TABLE 137 CANADA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 138 CANADA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 139 CANADA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 140 CANADA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 141 CANADA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 142 CANADA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 143 CANADA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 RECESSION IMPACT ON NORTH AMERICAN BASE EDITING MARKET
     11.3 EUROPE 
             TABLE 144 EUROPE: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 145 EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 146 EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 147 EUROPE: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 148 EUROPE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 149 EUROPE: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
             TABLE 150 EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 151 EUROPE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Strong academic base and rising awareness to drive growth
                                      TABLE 152 GERMANY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 153 GERMANY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 154 GERMANY: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 155 GERMANY: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 GERMANY: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 157 GERMANY: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 158 GERMANY: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Largest market for genome engineering in Europe
                                      TABLE 159 UK: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 160 UK: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 161 UK: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 162 UK: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 163 UK: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 164 UK: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 165 UK: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Government funding for genomics to support market growth
                                      TABLE 166 FRANCE: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 167 FRANCE: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 168 FRANCE: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 169 FRANCE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 170 FRANCE: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 171 FRANCE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 172 FRANCE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.4 ITALY
                        11.3.4.1 Increasing number of workshops and conferences to propel market growth
                                      TABLE 173 ITALY: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 174 ITALY: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 175 ITALY: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 176 ITALY: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 177 ITALY: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 178 ITALY: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 179 ITALY: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.5 SPAIN
                        11.3.5.1 Increased focus on personalized medicines to boost market growth
                                      TABLE 180 SPAIN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 181 SPAIN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 182 SPAIN: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 183 SPAIN: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 184 SPAIN: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 185 SPAIN: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 186 SPAIN: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.6 REST OF EUROPE
                        TABLE 187 REST OF EUROPE: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 188 REST OF EUROPE: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 189 REST OF EUROPE: BASE EDITING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 190 REST OF EUROPE: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 191 REST OF EUROPE: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
                        TABLE 192 REST OF EUROPE: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 193 REST OF EUROPE: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.3.7 RECESSION IMPACT ON EUROPEAN BASE EDITING MARKET
     11.4 ASIA PACIFIC 
             FIGURE 28 ASIA PACIFIC: BASE EDITING MARKET SNAPSHOT
             TABLE 194 ASIA PACIFIC: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 195 ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 196 ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 197 ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 198 ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 199 ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
             TABLE 200 ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 201 ASIA PACIFIC: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 Government support for genomics research to favor market growth
                                      TABLE 202 CHINA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 203 CHINA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 204 CHINA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 205 CHINA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 206 CHINA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 207 CHINA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 208 CHINA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Increased focus on cancer research to propel market
                                      TABLE 209 JAPAN: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 210 JAPAN: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 211 JAPAN: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 212 JAPAN: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 213 JAPAN: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 214 JAPAN: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 215 JAPAN: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Rising number of research activities to support market growth
                                      TABLE 216 INDIA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 217 INDIA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 218 INDIA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 219 INDIA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 220 INDIA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 221 INDIA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 222 INDIA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 SOUTH KOREA
                        11.4.4.1 Increasing focus on gene editing research and applications to drive market
                                      TABLE 223 SOUTH KOREA: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 224 SOUTH KOREA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 225 SOUTH KOREA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 226 SOUTH KOREA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 227 SOUTH KOREA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 228 SOUTH KOREA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 229 SOUTH KOREA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                        TABLE 230 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 231 REST OF ASIA PACIFIC: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 232 REST OF ASIA PACIFIC: BASE EDITING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 233 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 234 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
                        TABLE 235 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 236 REST OF ASIA PACIFIC: BASE EDITING MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.4.6 RECESSION IMPACT ON ASIA PACIFIC BASE EDITING MARKET
     11.5 LATIN AMERICA 
             TABLE 237 LATIN AMERICA: BASE EDITING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 238 LATIN AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 239 LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 240 LATIN AMERICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 241 LATIN AMERICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 242 LATIN AMERICA: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
             TABLE 243 LATIN AMERICA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 244 LATIN AMERICA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.1 BRAZIL
                        11.5.1.1 Need for advanced therapies to support market growth
                                      TABLE 245 BRAZIL: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 246 BRAZIL: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 247 BRAZIL: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 BRAZIL: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 249 BRAZIL: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 250 BRAZIL: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 251 BRAZIL: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.2 MEXICO
                        11.5.2.1 Rising demand for potential gene therapies to drive market
                                      TABLE 252 MEXICO: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 253 MEXICO: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 254 MEXICO: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 255 MEXICO: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 256 MEXICO: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 257 MEXICO: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 258 MEXICO: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.3 REST OF LATIN AMERICA
                        TABLE 259 REST OF LATIN AMERICA: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                        TABLE 260 REST OF LATIN AMERICA: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 261 REST OF LATIN AMERICA: BASE EDITING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 262 REST OF LATIN AMERICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 263 REST OF LATIN AMERICA: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
                        TABLE 264 REST OF LATIN AMERICA: BASE EDITING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                        TABLE 265 REST OF LATIN AMERICA: BASE EDITING MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.5.4 RECESSION IMPACT ON LATIN AMERICAN BASE EDITING MARKET
     11.6 MIDDLE EAST & AFRICA 
             TABLE 266 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY REGION, 2021–2028 (USD MILLION)
             TABLE 267 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 268 MIDDLE EAST & AFRICA: BASE EDITING PRODUCTS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 269 MIDDLE EAST & AFRICA: BASE EDITING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 270 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 271 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY TARGETED BASE,  2021–2028 (USD MILLION)
             TABLE 272 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
             TABLE 273 MIDDLE EAST & AFRICA: BASE EDITING MARKET, BY END USER,  2021–2028 (USD MILLION)
             11.6.1 MIDDLE EAST
                        11.6.1.1 Increased focus on personalized medicine and preventive healthcare to propel market
                                      TABLE 274 MIDDLE EAST: BASE EDITING MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 275 MIDDLE EAST: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 276 MIDDLE EAST: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 277 MIDDLE EAST: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 278 MIDDLE EAST: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 279 MIDDLE EAST: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 280 MIDDLE EAST: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.6.2 AFRICA
                        11.6.2.1 Rising number of government-funded projects to support market growth
                                      TABLE 281 AFRICA: BASE EDITING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 282 AFRICA: BASE EDITING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 283 AFRICA: BASE EDITING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 284 AFRICA: BASE EDITING MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 285 AFRICA: BASE EDITING MARKET, BY TARGETED BASE, 2021–2028 (USD MILLION)
                                      TABLE 286 AFRICA: BASE EDITING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 287 AFRICA: BASE EDITING MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.6.3 RECESSION IMPACT ON MIDDLE EAST & AFRICAN BASE EDITING MARKET
 
12 COMPETITIVE LANDSCAPE (Page No. - 215)
     12.1 OVERVIEW 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 29 STRATEGIES ADOPTED BY KEY PLAYERS, 2020−2023
     12.3 REVENUE SHARE ANALYSIS OF TOP FIVE MARKET PLAYERS 
             FIGURE 30 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS, 2018–2022 (USD MILLION)
     12.4 MARKET SHARE ANALYSIS 
             TABLE 288 BASE EDITING MARKET: INTENSITY OF COMPETITIVE RIVALRY
     12.5 COMPANY EVALUATION MATRIX 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 32 BASE EDITING MARKET: COMPANY EVALUATION MATRIX, 2022
             12.5.5 COMPANY FOOTPRINT
                        TABLE 289 OVERALL FOOTPRINT OF COMPANIES (2022)
                        12.5.5.1 Product & service footprint
                                      TABLE 290 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (2022)
                        12.5.5.2 Regional footprint
                                      TABLE 291 REGIONAL FOOTPRINT OF COMPANIES (2022)
     12.6 STARTUP/SME EVALUATION MATRIX 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 RESPONSIVE COMPANIES
             12.6.3 DYNAMIC COMPANIES
             12.6.4 STARTING BLOCKS
                        FIGURE 33 BASE EDITING MARKET: STARTUP/SME EVALUATION MATRIX, 2022
             12.6.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
                        TABLE 292 BASE EDITING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                        TABLE 293 BASE EDITING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
     12.7 COMPETITIVE SCENARIOS AND TRENDS 
             TABLE 294 BASE EDITING MARKET: PRODUCT & SERVICE LAUNCHES,  JANUARY 2020−NOVEMBER 2023
             TABLE 295 BASE EDITING MARKET: DEALS, JANUARY 2020−NOVEMBER 2023
             TABLE 296 BASE EDITING MARKET: OTHER DEVELOPMENTS, JANUARY 2020−NOVEMBER 2023
 
13 COMPANY PROFILES (Page No. - 228)
     13.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             13.1.1 DANAHER CORPORATION
                        TABLE 297 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.2 BEAM THERAPEUTICS
                        TABLE 298 BEAM THERAPEUTICS: BUSINESS OVERVIEW
                        FIGURE 35 BEAM THERAPEUTICS: COMPANY SNAPSHOT (2022)
             13.1.3 MERCK KGAA
                        TABLE 299 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2022)
             13.1.4 REVVITY
                        TABLE 300 REVVITY: BUSINESS OVERVIEW
                        FIGURE 37 REVVITY: COMPANY SNAPSHOT (2023)
             13.1.5 MARAVAI LIFESCIENCES
                        TABLE 301 MARAVAI LIFESCIENCES: BUSINESS OVERVIEW
                        FIGURE 38 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT (2022)
             13.1.6 GENSCRIPT
                        TABLE 302 GENSCRIPT: BUSINESS OVERVIEW
                        FIGURE 39 GENSCRIPT: COMPANY SNAPSHOT (2022)
             13.1.7 INTELLIA THERAPEUTICS, INC.
                        TABLE 303 INTELLIA THERAPEUTICS, INC.: BUSINESS OVERVIEW
                        FIGURE 40 INTELLIA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2022)
             13.1.8 CELLECTIS
                        TABLE 304 CELLECTIS: BUSINESS OVERVIEW
                        FIGURE 41 CELLECTIS: COMPANY SNAPSHOT (2022)
             13.1.9 ELEVATEBIO
                        TABLE 305 ELEVATEBIO: BUSINESS OVERVIEW
             13.1.10 CREATIVE BIOGENE
                        TABLE 306 CREATIVE BIOGENE: BUSINESS OVERVIEW
             13.1.11 BIO PALETTE CO., LTD.
                        TABLE 307 BIO PALETTE CO., LTD.: BUSINESS OVERVIEW
             13.1.12 ADDGENE
                        TABLE 308 ADDGENE: BUSINESS OVERVIEW
             13.1.13 SYNTHEGO
                        TABLE 309 SYNTHEGO: BUSINESS OVERVIEW
             13.1.14 EDIGENE INC.
                        TABLE 310 EDIGENE INC.: BUSINESS OVERVIEW
             13.1.15 SHAPETX
                        TABLE 311 SHAPETX: BUSINESS OVERVIEW
     13.2 OTHER PLAYERS 
             13.2.1 PAIRWISE
             13.2.2 PROQR THERAPEUTICS
             13.2.3 QI-BIODESIGN TECHNOLOGY
             13.2.4 KROMATID, INC.
             13.2.5 GENKORE
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 266)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global base editing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Base editing market. The secondary sources used for this study include Genome Canada, National Human Genome Research Institute (NHGRI), Asia Pacific Society of Human Genetics (APSHG), Genetics Society of America (GSA), European Society of Human Genetics (ESHG), Centers for Common Disease Genomics (CCDG), Genomics England, Center for Cellular and Molecular Biology (CCMB, India), Association for Clinical Genomic Science (ACGS), Japan Agency for Medical Research & Development, Department of Biotechnology (India), Center for Alternatives to Animal Testing (CAAT), National Institute of Environmental Health Sciences (NIEHS), United States Environmental Protection Agency (USEPA), US Food and Drug Administration (US FDA), US Census Bureau, Eurostat, Statista, and Factiva. The Scientist Magazine, ScienceDirect, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global base editing market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Base Editing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the base editing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the base editing business of leading players have been determined through primary and secondary research.

All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Base Editing Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Base Editing Market Size, and Share

Data Triangulation

To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

In the process of data triangulation, we employed a multifaceted approach, incorporating primary data collection methods, analysis of the MarketsandMarkets (MnM) repository, and a comprehensive examination of company shares. By integrating insights from these diverse sources, we derived a meticulously validated and reliable estimate for the final market size.

Market Definition

Base editing is a precise and targeted genome editing technique that allows for the specific modification of individual nucleotide bases in a DNA molecule without inducing double-strand breaks. This technology offers a highly controlled and minimally disruptive approach to genomic modifications, reducing the risk of off-target effects associated with other genome editing methods.

Stakeholders

  • Genome editing/genome engineering product manufacturers
  • Suppliers and distributors of genomic instruments/systems and consumables
  • Contract manufacturing organizations
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Government associations and research institutes
  • Healthcare associations/institutes
  • Regulatory authorities
  • Business research firms
  • Agricultural companies
  • Report Objectives
  • To define, describe, segment, and forecast the base editing market by product & service, type, application, end-user, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the market growth
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall base editing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the base editing market in five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, along with their respective key countries
  • To profile the key players in the base editing market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product & service launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the base editing market
  • To benchmark players within the base editing market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific base editing market into other Rest of Asian countries
  • A further breakdown of the Rest of European base editing market into other Rest of European countries
  • A further breakdown of the Rest of Latin American Base editing market into other Rest of Latin American countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
BT 8891
Published ON
Dec, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Base Editing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback